AxoGen Inc
F:LT3
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
AxoGen Inc
F:LT3
|
US |
|
S
|
Siemens AG
XMUN:SIE
|
DE |
Intrinsic Value
The intrinsic value of 
AxoGen Inc (LT3) under the Base Case is 23.6 EUR per share.
Compared with the current market price of 44.71 EUR, the stock appears
Overvalued by 47% .
The intrinsic value is the average of valuations using the DCF method and multiples.
Do our valuations actually work? See backtest results .
Cheap or expensive for this stock?
This block shows whether today’s valuation is cheap or expensive compared with the stock’s own history, and what happened after similar valuations in the past.
We compare the gap between the stock’s price and our estimated value over time.
- Undervalued can still be historically expensive. The stock may trade below our estimated value, but usually offer an even bigger discount.
- Overvalued can still be historically cheap. The stock may trade above our estimated value, but usually carry an even higher premium.
Market expectations can differ from our model, which may not fully capture everything affecting the price. That is why some stocks regularly trade above our estimated value and others below it.
The scale and chart show how today’s valuation compares with the past. The cards summarize past returns and waiting times until the stock stopped being cheap or expensive. This can happen because the price changed, our estimated value changed, or both.
Only completed periods are included. These are past results, not forecasts. The usual historical range does not necessarily mean fair value.
Fundamental Analysis
What AxoGen Does
AxoGen makes medical products used to repair and protect damaged peripheral nerves, the nerves outside the brain and spinal cord. Its main products are used by surgeons in procedures for traumatic injuries and other nerve damage, especially when a cut or loss of nerve tissue needs a bridge or protective wrap to help the nerve heal. The company’s business is built around selling these implantable nerve repair products to hospitals, surgical centers, and doctors who perform reconstructive and trauma surgery.
- Headquarters
- United States of America US
- Employees
- 622
- IPO date
- Dec 17, 1986
Revenue & Expenses Breakdown
AxoGen Inc
Earnings Waterfall
AxoGen Inc
The intrinsic value for AxoGen Inc (LT3) under the Base Case is 23.6 EUR.
Compared with the current market price of 44.71 EUR, the stock appears Overvalued by 47% .